or
forgot password
  • cancer clinical trials in stony brook, NY

  • Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Lung Cancer
    Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Breast Cancer
    T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Precancerous Condition
    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Lymphoma
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Sarcoma
    Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Colorectal Cancer
    Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Leukemia
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Leukemia
    Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Leukemia, Myelodysplastic Syndromes, Sarcoma
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Brain and Central Nervous System Tumors
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Sarcoma
    STI571 in Treating Patients With Recurrent Leukemia
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Leukemia
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Brain and Central Nervous System Tumors
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Leukemia
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    State University of New York Health Sciences Center - Stony Brook
    Stony Brook, New York 11790-7775
    Colorectal Cancer
    Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Leukemia, Lymphoma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Breast Cancer
    A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
    University Hospital Stony Brook
    Stony Brook, New York 11794
    Multiple Sclerosis, Relapsing-Remitting
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Endometrial Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Kidney Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Brain Tumor, Central Nervous System Tumor
    Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Long Island Cancer Center at Stony Brook University Hospital
    Stony Brook, New York 11790-7775
    Kidney Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Brain Tumor, Central Nervous System Tumor
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    SUNY at Stony Brook Hospital Medical Center
    Stony Brook, New York 11794-8191
    Melanoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Kidney Cancer
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Breast Cancer
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    VEGF Trap in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Recurrent Endometrial Carcinoma
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Derm Research Center of New York, Inc.
    Stony Brook, New York 11790
    Atopic Dermatitis
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Endometrial Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Leukemia
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Colorectal Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    SUNY - Stony Brook University
    Stony Brook, New York 11794-8121
    Primary Progressive Multiple Sclerosis
    Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
    Stony Brook Cancer Center (SUNY)
    Stony Brook, New York 11794
    Lung Cancer, Non Small Cell Lung Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Stony Brook University Medical Center
    Stony Brook, New York 11794
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Endometrial Cancer, Fatigue, Neurotoxicity
    Strategic Timing of Antiretroviral Treatment
    SUNY Stony Brook
    Stony Brook, New York 11733
    HIV Infection
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Stony Brook University Cancer Center
    Stony Brook, New York 11794-8174
    Leukemia, Lymphoma